Skip to content

Clinical trials

Expanded access trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Canada Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20051
20063
20091
20111
20121
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available24
Approved for marketing15
Available6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Pfizer6
Bristol-Myers Squibb4
Eisai Inc.3
Bayer2
British Columbia Cancer Agency2
Eli Lilly and Company2
Gilead Sciences2
Nuvalent Inc.2
Tibotec Pharmaceuticals, Ireland2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma4
Breast Neoplasms3
Carcinoma, Renal Cell3
HIV Infections3
Recurrence3
Carcinoma, Non-Small-Cell Lung2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Leukemia, Myeloid, Acute2
Sarcoma2
Angioedema1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.